A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast Cancer

NCT01121549 · clinicaltrials.gov ↗
TERMINATED
Status
378
Enrollment
INDUSTRY
Sponsor class

Stopped See termination reason in detailed description.

Conditions

Interventions

Sponsor

Pfizer